NPPA and Abnormal renal physiology: In renal IRI, the administration of atrial natriuretic peptide (ANP) has been shown to cause attenuation in the IRI‐induced renal dysfunction (Chujo et al., 2008; Mitaka et al., 2014; Moriyama et al., 2016).